Detalles de la búsqueda
1.
Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.
Front Pharmacol
; 13: 837632, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35392566
2.
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis.
Front Pharmacol
; 12: 773875, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34899334
3.
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis.
medRxiv
; 2020 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269355
4.
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States.
medRxiv
; 2020 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140068
5.
Future Discounting Bias and Scenarios Without Lock-Step FEV1/Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations.
Chest
; 163(4): e193-e194, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031993
6.
Regarding the article entitled "Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis".
J Cyst Fibros
; 22(3): 587, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948912
Resultados
1 -
6
de 6
1
Próxima >
>>